Literature DB >> 28932562

Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients.

Duilio Divisi1, Mirko Barone1, Luca Bertolaccini2, Gaetano Rocco3, Piergiorgio Solli2, Roberto Crisci1.   

Abstract

BACKGROUND: Multislice computed tomography (MSCT) increased detection of solitary pulmonary nodules (SPNs), changing the management based on radiological and clinical factors. When 18-fluorine fluorodeoxyglucose positron emission tomography combined with computed tomography (18F-FDG-PET/CT) was considered for the evaluation of nodules, the maximum standardized uptake value (SUVmax) more than 2.5 is used frequently as a cut off for malignancy. The purpose of this study is to evaluate SUVmax PET/CT and pulmonary attenuation patterns at MSCT in patients with SPN according to morphological and pathological characteristics of the lesion.
METHODS: A retrospective study on 1,592 SPN patients was carried out following approval by the Italian Registry of VATS Lobectomies.
RESULTS: All patients underwent VATS lobectomy. On histologic examination, 98.1% had primary or second metachronous primary lung cancers. In addition, 10.7% presented occult lymph node metastases (pN1 or pN2) on histological examination. Nodule attenuation on CT was associated with the histology of the lesion (p= 0.030); in particular, pure ground glass opacities (pGGOs) and partially solid nodules were related to adenocarcinomatous histotypes. Conversely, a significant relationship between SUVmax and age, nodule size, pathological node status (pN) was found (P=0.007, P=0.000 and P=0.002 respectively).
CONCLUSIONS: Nodule attenuation can predict the histology of the lesion whereas SUVmax may relate to the propensity to lymph node metastases.

Entities:  

Keywords:  Solitary pulmonary nodule (SPN); ground glass opacities; lung adenocarcinoma; lymph node metastases; maximum standardized uptake value

Year:  2017        PMID: 28932562      PMCID: PMC5594188          DOI: 10.21037/jtd.2017.06.124

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  32 in total

1.  False-positive FDG positron emission tomography in pulmonary amyloidosis.

Authors:  Glenn P Ollenberger; Simon Knight; Andrew J Tauro
Journal:  Clin Nucl Med       Date:  2004-10       Impact factor: 7.794

2.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.

Authors:  Heber MacMahon; John H M Austin; Gordon Gamsu; Christian J Herold; James R Jett; David P Naidich; Edward F Patz; Stephen J Swensen
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

3.  Evaluation of primary pulmonary carcinoid tumors using FDG PET.

Authors:  J J Erasmus; H P McAdams; E F Patz; R E Coleman; V Ahuja; P C Goodman
Journal:  AJR Am J Roentgenol       Date:  1998-05       Impact factor: 3.959

4.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

Review 5.  Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.

Authors:  Ho Yun Lee; Kyung Soo Lee
Journal:  J Thorac Imaging       Date:  2011-05       Impact factor: 3.000

Review 6.  Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings.

Authors:  K S Lee; Y Kim; J Han; E J Ko; C K Park; S L Primack
Journal:  Radiographics       Date:  1997 Nov-Dec       Impact factor: 5.333

7.  [Correlation analysis between imaging features and lymph node metastasis in T1a lung adenocarcinoma].

Authors:  Bo Ye; Jian Feng; Xu-feng Pan; Yu Yang; Jun-feng Geng; Ke-jian Cao; Heng Zhao; Ding-zhong Hu
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2013-10

8.  Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.

Authors:  Hiroaki Nomori; Kenichi Watanabe; Takashi Ohtsuka; Tsuguo Naruke; Keiichi Suemasu; Kimiichi Uno
Journal:  Lung Cancer       Date:  2004-07       Impact factor: 5.705

9.  Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.

Authors:  Chao-Jung Chen; Bi-Fang Lee; Wei-Jen Yao; Lili Cheng; Pei-Shan Wu; Ching Lin Chu; Nan-Tsing Chiu
Journal:  AJR Am J Roentgenol       Date:  2008-08       Impact factor: 3.959

10.  Risk factors for mediastinal lymph node metastasis in non-small-cell lung cancer by PET/CT.

Authors:  Ze-qing Xu; Liang-jun Xie; Wei Fan; Xiao-bei Duan; Mu-hua Cheng
Journal:  Nucl Med Commun       Date:  2014-05       Impact factor: 1.690

View more
  3 in total

1.  Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.

Authors:  Cheng Ding; Xiaofei Zhou; Chun Xu; Jun Chen; Shen Ju; Tengfei Chen; Zhipan Liang; Zihan Cui; Chang Li; Jun Zhao
Journal:  Thorac Cancer       Date:  2018-09-04       Impact factor: 3.500

2.  Solitary Pulmonary Nodule: Morphological Effects on Metabolic Activity Assessment

Authors:  Mehmet Erdoğan; Şehnaz Evrimler; Hüseyin Aydın; Adnan Karaibrahimoğlu; Sevim Süreyya Şengül
Journal:  Mol Imaging Radionucl Ther       Date:  2019-09-06

3.  Predictive model for the diagnosis of benign/malignant small pulmonary nodules.

Authors:  Weisong Chen; Dan Zhu; Hui Chen; Jianfeng Luo; Haiwei Fu
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.